AshiBio
Burlingame, US · 2 known investors
āshibio is a biotech company developing novel therapies for rare bone and connective tissue disorders, led by a team of scientists, physicians and drug developers. Its lead product is the antibody andecaliximab.
Founders & leadership
PB
Pankaj BhargavaFounder & Chief Executive Officer
VS
Victoria SmithChief Scientific Officer
DW
Deborah WenkertChief Medical Officer
JS
Joseph SarretActing Chief Operating Officer
BS
Brian ShusterActing Chief Business Officer
Investors · 2
Competitors · 7
by search overlap
AskBio5 shared keywordsAskBio is a gene therapy company developing adeno-associated virus (AAV)-based genetic medicines for rare and other diseases, with clinical programs such as AB-1009 for late-onset Pompe disease. It operates as a wholly owned, independent subsidiary of Bayer AG.
Azbio4 shared keywordsAZBio (Arizona Bioindustry Association) is a statewide membership organization supporting and advocating for Arizona's life science and bioscience industry, including companies in medicines, medical devices, diagnostics, and health technologies. It connects member organizations across business, research, education, healthcare, and government, and works with national bodies such as BIO, AdvaMed, MDMA, and PhRMA.
Axbio4 shared keywordsAXBIO builds a microfluidic Bio-CMOS platform combining nanopore sequencing, CMOS chips, and electrochemical sensors for high-throughput gene sequencing and molecular diagnostics. Its products include an EL-NGS gene sequencing platform, a multiplex nucleic acid analysis platform, and related reagents.
Akamis Bio4 shared keywordsAkamis Bio develops oncolytic immunotherapies for colorectal cancer treatment, aiming to offer alternatives to surgery that preserve patient function and quality of life. The company serves patients and clinicians in the oncology market.
AviadoBio Website3 shared keywordsAviadoBio is a gene therapy company developing adeno-associated viral (AAV) treatments for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). It is a spinout from King's College London research focused on the genetics and molecular biology of these diseases.
HiFiBiO Therapeutics3 shared keywordsHiFiBiO Therapeutics develops immunotherapies for patients with high unmet medical needs, using its Drug Intelligence Science (DIS) platform that combines single cell technology with AI/ML analytics. The platform supports target discovery, antibody selection, and predictive biomarker identification for drug development.
Avivo Biomedical Inc.3 shared keywordsAvivoBio develops enzyme-based technology to convert blood and donor organs into a universal type O, removing ABO blood-type incompatibility as a barrier to transfusions and organ transplants. Its work targets clinicians and the transplant field, aiming to match donations by medical need rather than blood type.
Companies competing with AshiBio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does AshiBio do?
- āshibio is a biotech company developing novel therapies for rare bone and connective tissue disorders, led by a team of scientists, physicians and drug developers. Its lead product is the antibody andecaliximab.
- Who founded AshiBio?
- AshiBio was founded by Pankaj Bhargava.
- Who are AshiBio's investors?
- AshiBio's investors include Agent Capital, MPM BioImpact.
- Where is AshiBio headquartered?
- AshiBio is headquartered in Burlingame, US.